跳至主要内容
临床试验/NCT02302690
NCT02302690已完成不适用

Study of the Prevalence of Pre-existing Immunity Against the Adeno-associated Virus (AAV) in Patients With Crigler-Najjar Syndrome

Genethon1 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2014年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Genethon
入组人数
49
试验地点
1
主要终点
To assess the presence of neutralizing AAV antibodies in the serum of CN patients

研究概览

简要总结

The proposed research protocol aims at addressing these points by pre-screening CN patients for their AAV serology in link with their medical history and current medical status. A first objective is to assess the presence of neutralizing AAV antibodies in the serum of CN patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • The patient has a Crigler-Najjar syndrome
  • The molecular diagnosis has been confirmed by UGT1A1 gene DNA sequencing
  • Exclusion criteria:
  • The patient is liver transplanted
  • The patient is suffering from severe associated pathologies precluding further enrolment in a future interventional clinical study

排除标准

  • 未提供

结局指标

主要结局

To assess the presence of neutralizing AAV antibodies in the serum of CN patients

时间窗: 1 day visit

次要结局

未报告次要终点

研究者

发起方
Genethon
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验